Clinical Trials

Showing trials with last updates posted in 2018.

NCT00012298 | TERMINATED | PHASE1/PHASE2
81 participants

Radiolabeled Monoclonal Antibody Plus Rituximab With and Without Filgrastim and Interleukin-11 in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma

Study Type:
INTERVENTIONAL
Last Updated:
2018-08-09
Start Date:
2001-04-30
Completion:
2010-04-30
Conditions
  • Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue
  • Nodal Marginal Zone B-cell Lymphoma
  • Recurrent Grade 1 Follicular Lymphoma
  • Recurrent Grade 2 Follicular Lymphoma
  • Recurrent Grade 3 Follicular Lymphoma
  • Recurrent Marginal Zone Lymphoma
  • Recurrent Small Lymphocytic Lymphoma
  • Splenic Marginal Zone Lymphoma
  • Waldenström Macroglobulinemia
Interventions
  • BIOLOGICAL
Previous
Sorted by latest updates
Next
Showing 40 trials per page